Editorial: Innovative organoid co-culture systems for enhanced precision medicine in cancer and beyond - Takeaways - MDSpire

Editorial: Innovative organoid co-culture systems for enhanced precision medicine in cancer and beyond

  • By

  • Talita Glaser

  • Rupert Ecker

  • Uwe Ritter

  • May 27, 2026

Share

  • 1

    Organoid co-culture systems closely mimic tissue microenvironments, enhancing precision medicine in oncology and other fields.

  • 2

    Patient-derived organoids facilitate mechanistic studies and individualized predictions of treatment response, despite clinical translation challenges.

  • 3

    Type I interferons' effects on gut functionality can be studied using patient-derived intestinal organoids, highlighting the importance of immune and microbial components.

  • 4

    A 3D ex vivo platform for colorectal cancer allows functional screening of PD-1 blockade, revealing the impact of immune context on treatment response.

  • 5

    Osteochondral organoids show promise for osteoarthritis research, emphasizing the need for interdisciplinary approaches to overcome translational barriers.

Original Source(s)

Editorial: Innovative organoid co-culture systems for enhanced precision medicine in cancer and beyond

  • by Talita Glaser, Rupert Ecker, Uwe Ritter

  • May 27, 2026

Related Content

When Insight Meets Urgency in Cell and Gene Therapy

Balancing deep biological insight with the realities of development is now central to progress in advanced medicine

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • by

  • May 26, 2026

  • 5 min
This Week’s Biopharma News: ADCs, Biosimilars, and Microbiome Moves

Merck’s TROP2 ADC delivers a phase III win in endometrial cancer, as new golimumab biosimilars and an oral microbiome therapy move forward

  • May 26, 2026

  • 9 min